Appendix 편집하기 (부분)

== TABLE 2. Clinical Chemistry and Immunology ==
{| class="wikitable"
! colspan="3" |Analyte
!Specimen
!SI Units
!Conventional Units
|-
| colspan="3" |Acetoacetate
|P
|49-294μmol/L
|0.5-3.0mg/dL
|-
| colspan="3" |Adrenocorticotropin (ACTH)
|P
|1.3-16.7pmol/L
|6.0-76.0pg/mL
|-
| colspan="3" |Alanine aminotransferase (ALT, SGPT)
|S
|0.12-0.70μkat/L
|7-41U/L
|-
| colspan="3" |Albumin
|S
|40-50g/L
|4.0-5.0mg/dL
|-
| colspan="3" |Aldolase
|S
|26-138nkat/L
|1.5-8.1U/L
|-
| colspan="3" |Aldosterone (adult)
|
|
|
|-
|
| colspan="2" |Supine, normal sodium diet
|S, P 
|<443pmol/L 
|<16ng/dL 
|-
|
| colspan="2" |Upright, normal
|S, P 
|111-858pmol/L
|4-31ng/dL
|-
| colspan="3" |Alpha fetoprotein (adult)
|
|0-8.5μg/L
|0-8.5ng/mL
|-
| colspan="3" |Alpha1 antitrypsin
|
|1.0-2.0g/L
|100-200mg/dL
|-
| colspan="3" |Ammonia, as NH<sub>3</sub>
|
|11-35μmol/L
|19-60 μg/dL
|-
| colspan="3" |Amylase
|
|0.34-1.6 μkat/L
|20-96U/L
|-
| colspan="3" |Androstendione (adult) 
|
|
|
|-
|
| colspan="2" |Males 
|
|0.81-3.1nmol/L
|23-89ng/dL
|-
|
| colspan="2" |Females
|
|
|
|-
|
|
|Premenopausal
|
|0.91-7.5nmol/L 
|26-214ng/dL
|-
|
|
|Postmenopausal
|
|0.46-2.9nmol/L
|13-82ng/dL
|-
| colspan="3" |Angiotensin-converting enzyme (ACE)
|S
|0.15-1.1μkat/L
|9-67U/L
|-
| colspan="3" |Anion gap
|S
|7-16mmol/L
|7-16mmol/L
|-
| colspan="3" |Apolipoprotein A-1 
|S
|
|
|-
|
| colspan="2" |Male
|
|0.94-1.78g/L
|94-178mg/dL
|-
|
| colspan="2" |Female
|
|1.01-1.99g/L
|101-199mg/dL
|-
| colspan="3" |Apolipoprotein B 
|S
|
|
|-
|
| colspan="2" |Male
|
|0.55-1.40g/L
|55-140mg/dL
|-
|
| colspan="2" |Female
|
|0.55-1.25g/L
|55-125mg/dL
|-
| colspan="3" |Arterial blood gases
|WB
|
|
|-
|
| colspan="2" |[HCO<sub>3</sub>- ]
|
|22-30mmol/L
|22-30meq/L 
|-
|
| colspan="2" |PCO<sub>2</sub>
|
|4.3-6.0kPa 
|32-45mmHg 
|-
|
| colspan="2" |pH 
|
|7.35-7.45 
|7.35-7.45 
|-
|
| colspan="2" |PO<sub>2</sub>
|
|9.6-13.8kPa
|72-104mmHg
|-
| colspan="3" |Aspartate aminotransferase (AST, SGOT)
|S
|0.20-0.65μkat/L
|12-38U/L
|-
| colspan="3" |B-type natriuretic peptide (BNP)
|P
|Age and gender specific: <100ng/L
|Age and gender specific: <100pg/mL 
|-
| colspan="3" |Bilirubin 
|S
|
|
|-
|
| colspan="2" |Total
|
|5.1-22μmol/L 
|0.3-1.3mg/dL 
|-
|
| colspan="2" |Direct 
|
|1.7-6.8μmol/L
|0.1-0.4mg/dL 
|-
|
| colspan="2" |Indirect
|
|3.4-15.2μmol/L
|0.2-0.9mg/dL
|-
| colspan="3" |C peptide
|S
|0.27-1.19nmol/L
|0.8-3.5ng/mL
|-
|
| colspan="2" |C1-esterase-inhibitor protein
|S
|210-390mg/L
|21-39mg/dL
|-
| colspan="3" |CA 125 
|S
|<35kU/L
|<35U/mL
|-
| colspan="3" |CA 19-9
|S
|<37kU/L
|<37U/mL
|-
| colspan="3" |CA 15-3
|S 
|<33kU/L
|<33U/mL
|-
| colspan="3" |CA 27-29
|S 
|0-40kU/L
|0-40U/mL
|-
| colspan="3" |Calcitonin
|S 
|
|
|-
|
| colspan="2" |Male
|
|0-7.5ng/L
|0-7.5pg/mL
|-
|
| colspan="2" |Female
|
|0-5.1ng/L
|0-5.1pg/mL
|-
| colspan="3" |Calcium
|S 
|2.2-2.6mmol/L
|8.7-10.2mg/dL
|-
|
| colspan="2" |Calcium, ionized
|WB
|1.12-1.32mmol/L
|4.5-5.3mg/dL
|-
| colspan="3" |Carbon dioxide content (TCO<sub>2</sub>)
|P (sea level)
|22-30mmol/L
|22-30meq/L
|-
| colspan="3" |Carboxyhemoglobin (carbon monoxide content)
|WB
|
|
|-
|
| colspan="2" |Nonsmokers
|
|0.0-0.015 
|0-1.5%
|-
|
| colspan="2" |Smokers
|
|0.04-0.09
|4-9% 
|-
| colspan="3" |Loss of consciousness and death
|
|>0.50
|>50%
|-
| colspan="3" |Carcinoembryonic antigen (CEA) 
|S
|
|
|-
|
|
|Nonsmokers
|
|0.0-3.0μg/L 
|0.0-3.0ng/mL
|-
|
|
|Smokers
|
|0.0-5.0μg/L
|0.0-5.0ng/mL
|-
|
| colspan="2" |Ceruloplasmin
|S
|250-630mg/L
|25-63mg/dL
|-
|
| colspan="2" |Chloride
|S
|102-109mmol/L
|102-109meq/L
|-
| colspan="3" |Cholinesterase
|S
|5-12kU/L
|5-12U/mL
|-
| colspan="3" |Chromogranin A
|S
|0-50μg/L
|0-50ng/mL
|-
| colspan="3" |Complement 
|S
|
|
|-
|
| colspan="2" |C3
|
|0.83-1.77g/L 
|83-177mg/dL
|-
|
| colspan="2" |C4
|
|0.16-0.47g/L
|16-47mg/dL 
|-
| colspan="3" |Complement total
|
|60-144CAE units
|60-144CAE units
|-
| colspan="3" |Cortisol
|S
|
|
|-
|
| colspan="2" |Fasting, 8 <sub>A.M.</sub>-12 noon
|
|138-690nmol/L
|5-25μg/dL 
|-
|
| colspan="2" |12 noon-8 <sub>P.M</sub>
|
|138-414nmol/L 
|5-15μg/dL
|-
|
| colspan="2" |8 <sub>P.M.</sub>-8 <sub>A.M</sub>
|
|0-276nmol/L
|0-10μg/dL
|-
|
| colspan="2" |C-reactive protein
|S
|<10mg/L
|<10mg/L
|-
|
| colspan="2" |C-reactive protein, high sensitivity
|S
|Cardiac risk
|Cardiac risk
|-
| colspan="3" |
|
|Low: <1.0mg/L 
|Low: <1.0mg/L 
|-
| colspan="3" |
|
|Average: 1.0-3.0mg/L
|Average: 1.0-3.0mg/L 
|-
| colspan="3" |
|
|High: >3.0mg/L
|High: >3.0mg/L
|-
| colspan="3" |Creatine kinase (total) 
|S
|
|
|-
|
| colspan="2" |Females
|
|0.66-4.0μkat/L
|39-238U/L 
|-
|
| colspan="2" |Males
|
|0.87-5.0μkat/L
|51-294U/L
|-
| colspan="3" |Creatine kinase-MB
|S
|
|
|-
|
| colspan="2" |Mass
|
|0.0-5.5μg/L
|0.0-5.5ng/mL 
|-
|
| colspan="2" |Fraction of total activity (by electrophoresis)
|
|0-0.04
|0-4.0%
|-
| colspan="3" |Creatinine 
|S
|
|
|-
|
| colspan="2" |Female
|
|44-80μmol/L 
|0.5-0.9mg/dL 
|-
|
| colspan="2" |Male
|
|53-106μmol/L
|0.6-1.2mg/dL
|-
| colspan="3" |Dehydroepiandrosterone (DHEA) (adult) 
|S
|
|
|-
|
| colspan="2" |Male
|
|6.2-43.4nmol/L
|180-1250ng/dL 
|-
|
| colspan="2" |Female
|
|4.5-34.0nmol/L
|130-980ng/dL
|-
| colspan="3" |Dehydroepiandrosterone (DHEA) sulfate 
|S
|
|
|-
|
| colspan="2" |Male (adult)
|
|100-6190μg/L 
|10-619μg/dL 
|-
|
| colspan="2" |Female (adult, premenopausal) 
|
|120-5350μg/L 
|12-535μg/dL
|-
|
| colspan="2" |Female (adult, postmenopausal)
|
|300-2600μg/L
|30-260μg/dL
|-
|
| colspan="2" |11-Deoxycortisol (adult)(compound S)
|S
|0.34-4.56nmol/L
|12-158ng/dL
|-
| colspan="3" |Dihydrotestosterone
|S, P
|
|
|-
|
| colspan="2" |Male
|
|1.03-2.92nmol/L 
|30-85ng/dL 
|-
|
| colspan="2" |Female
|
|0.14-0.76nmol/L
|4-22ng/dL
|-
| colspan="3" |Dopamine
|P
|0-130pmol/L
|0-20pg/mL
|-
| colspan="3" |Epinephrine
|P
|
|
|-
|
| colspan="2" |Supine (30 min) 
|
|<273pmol/L
|<50pg/mL 
|-
|
| colspan="2" |Sitting
|
|<328pmol/L
|<60pg/mL
|-
|
| colspan="2" |Standing (30 min)
|
|<491pmol/L
|<90pg/mL
|-
| colspan="3" |Erythropoietin
|S
|4-27U/L
|4-27U/L 
|-
| colspan="3" |Estradiol
|S, P
|
|
|-
|
| colspan="2" |Female
|
|
|
|-
|
| colspan="2" |Menstruating: 
|
|
|
|-
|
|
|Follicular phase
|
|74-532pmol/L
|<20-145pg/mL
|-
|
|
|Midcycle peak 
|
|411-1626pmol/L 
|112-443pg/mL 
|-
|
|
|Luteal phase
|
|74-885pmol/L
|<20-241pg/mL 
|-
|
| colspan="2" |Postmenopausal 
|
|217pmol/L
|<59pg/mL 
|-
|
| colspan="2" |Male
|
|74pmol/L
|<20pg/mL
|-
| colspan="3" |Estrone 
|S, P
|
|
|-
|
| colspan="2" |Female
|
|
|
|-
|
| colspan="2" |Menstruating: 
|
|
|
|-
|
|
|Follicular phase 
|
|<555pmol/L 
|<150pg/mL 
|-
|
|
|Luteal phase
|
|<740pmol/L 
|<200pg/mL 
|-
|
|
|Postmenopausal
|
|11-118pmol/L 
|3-32pg/mL
|-
|
| colspan="2" |Male
|
|33-133pmol/L
|9-36pg/mL
|-
|
| colspan="2" |Fatty acids, free (nonesterified)
|P
|0.1-0.6mmol/L
|2.8-16.8mg/dL
|-
| colspan="3" |Ferritin
|S
|
|
|-
|
| colspan="2" |Female
|
|10-150μg/L 
|10-150ng/mL 
|-
|
| colspan="2" |Male
|
|29-248μg/L
|29-248ng/mL
|-
| colspan="3" |Follicle-stimulating hormone (FSH) S, P
|
|
|
|-
|
| colspan="2" |Female
|
|
|
|-
|
|
|Menstruating 
|
|
|
|-
|
|
|<blockquote>Follicular phase</blockquote>
|
|3.0-20.0IU/L
|3.0-20.0mIU/mL
|-
|
|
|<blockquote>Ovulatory phase</blockquote>
|
|9.0-26.0IU/L 
|9.0-26.0mIU/mL
|-
|
|
|<blockquote>Luteal phase</blockquote>
|
|1.0-12.0IU/L 
|1.0-12.0mIU/mL 
|-
|
|
|Postmenopausal
|
|18.0-153.0IU/L
|18.0-153.0mIU/mL
|-
|
| colspan="2" |Male
|
|1.0-12.0IU/L
|1.0-12.0mIU/mL
|-
|
| colspan="2" |Fructosamine
|S 
|<285umol/L
|<285umol/L
|-
| colspan="3" |Gamma glutamyltransferase
|S 
|0.15-0.99μkat/L
|9-58U/L
|-
|
| colspan="2" |Gastrin
|S 
|<100ng/L
|<100pg/mL
|-
| colspan="3" |Glucagon
|P
|40-130ng/L
|40-130pg/mL
|-
| colspan="3" |Glucose
|WB
|3.6-5.3mmol/L
|65-95mg/dL
|-
| colspan="3" |Glucose (fasting)
|P
|
|
|-
|
| colspan="2" |Normal
|
|4.2-5.6mmol/L 
|75-100mg/dL 
|-
|
| colspan="2" |Increased risk for diabetes 
|
|5.6-6.9mmol/L
|100-125mg/dL
|-
| colspan="3" |Diabetes mellitus
|
|Fasting ≥7.0 mmol/L
|Fasting ≥126mg/dL
|-
| colspan="4" |
|A 2-hour level of ≥11.1mmol/L during an oral glucose tolerance
|A 2-hour level of ≥ 200mg/dL during an oral glucose
|-
| colspan="4" |
|test
|tolerance test
|-
| colspan="4" |
|A random glucose level of ≥11.1mmol/L in patients with symptoms of hyperglycemia
|A random glucose level of ≥200mg/dL in patients with symptoms of hyperglycemia
|-
|
| colspan="2" |Growth hormone
|S
|0-5μg/L
|0-5ng/mL
|-
| colspan="3" |Hemoglobin A<sub>1c</sub>
|WB
|
|
|-
|
| colspan="2" |Pre-diabetes 
|
|0.04-0.06 HgB fraction
|4.0-5.6% 
|-
|
| colspan="2" |Diabetes mellitus
|
|0.057-0.064 HgB fraction
|5.7-6.4%
|-
|
| colspan="2" |
|
|A hemoglobin A1c level of ≥0.065 Hgb fraction as suggestedby the American Diabetes Association
|A hemoglobin A1c level of  ≥6.5% as suggested by the American Diabetes Association
|-
| colspan="3" |Hemoglobin A<sub>1c</sub> with estimated average 
|WB
|eAg mmoL/L=
|eAg (mg/dL)=
|-
|
| colspan="2" |glucose (eAg)
|
|1.59×HbA1c-2.59
|28.7×HbA1c-46.7
|-
| colspan="3" |Human chorionic gonadotropin (HCG) 
|S
|
|
|-
|
| colspan="2" |Nonpregnant female
|
|<5IU/L
|<5mIU/ml
|-
|
| colspan="2" |1-2weeks postconception
|
|9-130IU/L
|9-130mIU/mL
|-
|
| colspan="2" |2-3weeks postconception
|
|75-2600IU/L 
|75-2600mIU/mL 
|-
|
| colspan="2" |3-4weeks postconception
|
|850-20,800IU/L
|850-20,800mIU/mL 
|-
|
| colspan="2" |4-5weeks postconception
|
|4,000-100,200IU/L 
|4,000-100,200mIU/mL 
|-
|
| colspan="2" |5-10weeks postconception
|
|11,500-289,000IU/L
|11,500-289,000mIU/mL 
|-
|
| colspan="2" |10-14weeks post conception
|
|18,300-137,000IU/L 
|18,300-137,000mIU/mL 
|-
|
| colspan="2" |Second trimester
|
|1,400-53,000 U/L 
|1400-53,000mIU/mL 
|-
| colspan="3" |Third trimester
|
|940-60,000IU/L
|940-60,000mIU/mL
|-
| colspan="3" |β-Hydroxybutyrate
|P
|60-170μmol/L
|0.6-1.8mg/dL
|-
| colspan="3" |17-Hydroxyprogesterone (adult) 
|S
|
|
|-
|
| colspan="2" |Male
|
|<4.17nmol/L
|<139ng/dL
|-
|
| colspan="2" |Female
|
|
|
|-
|
|
|Follicular phase 
|
|0.45-2.1nmol/L
|15-70ng/dL
|-
|
|
|Luteal phase
|
|1.05-8.7nmol/L
|35-290ng/dL
|-
| colspan="3" |Lactate
|P, arterial 
|0.5-1.6mmol/L
|4.5-14.4mg/dL
|-
| colspan="3" |
|P, venous
|0.5-2.2mmol/L
|4.5-19.8mg/dL
|-
| colspan="3" |Lactate dehydrogenase
|S
|2.0-3.8μkat/L
|115-221U/L
|-
| colspan="3" |Lipase
|S
|0.51-0.73μkat/L
|3-43U/L
|-
|
| colspan="2" |Lipoprotein (a)
|S
|0-300mg/L
|0-30mg/dL
|-
| colspan="3" |Luteinizing hormone (LH) 
|S, P
|
|
|-
|
| colspan="2" |Female
|
|
|
|-
|
|
|Menstruating
|
|
|
|-
|
|
|Follicular phase
|
|2.0-15.0U/L 
|2.0-15.0mIU/mL
|-
|
|
|Ovulatory phase 
|
|22.0-105.0U/L 
|22.0-105.0mIU/mL
|-
|
|
|Luteal phase
|
|0.6-19.0U/L 
|0.6-19.0mIU/mL 
|-
|
|
|Postmenopausal 
|
|16.0-64.0U/L 
|16.0-64.0mIU/mL 
|-
|
| colspan="2" |Male
|
|2.0-12.0U/L
|2.0-12.0mIU/mL
|-
| colspan="3" |Magnesium
|S
|0.62-0.95mmol/L
|1.5-2.3mg/dL
|-
| colspan="3" |Metanephrine
|P
|<0.5nmol/L
|<100pg/mL
|-
| colspan="3" |Methemoglobin
|WB
|0.0-0.01
|0-1%
|-
| colspan="3" |Myoglobin 
|S
|
|
|-
|
| colspan="2" |Male
|
|20-71μg/L 
|20-71μg/L 
|-
|
| colspan="2" |Female
|
|25-58μg/L
|25-58μg/L
|-
| colspan="3" |Norepinephrine 
|P
|
|
|-
|
| colspan="2" |Supine (30 min)
|
|650-2,423pmol/L
|110-410pg/mL 
|-
|
| colspan="2" |Sitting
|
|709-4,019pmol/L
|120-680pg/mL 
|-
|
| colspan="2" |Standing (30 min)
|
|739-4,137pmol/L
|125-700pg/mL
|-
| colspan="3" |Osmolality
|P
|275-295 mOsmol/kg serum
|275-295mOsmol/kg serum
|-
|
| colspan="2" |
|
|water
|water
|-
| colspan="3" |Osteocalcin
|S
|11-50μg/L
|11-50ng/mL
|-
| colspan="3" |Oxygen content 
|WB
|
|
|-
|
| colspan="2" |Arterial (sea level) 
|
|17-21 
|17-21vol% 
|-
|
| colspan="2" |Venous (sea level)
|
|10-16
|10-16vol%
|-
| colspan="3" |Oxygen saturation (sea level)
|WB
|Fraction:
|Percent:
|-
|
| colspan="2" |Arterial
|
|0.94-1.0 
|94-100%
|-
|
| colspan="2" |Venous, arm
|
|0.60-0.85
|60-85%
|-
| colspan="3" |Parathyroid hormone (intact)
|S
|8-51ng/L
|8-51g/mL
|-
| colspan="3" |Phosphatase, alkaline
|S
|0.56-1.63μkat/L
|33-96U/L
|-
| colspan="3" |Phosphorus, inorganic
|S
|0.81-1.4mmol/L
|2.5-4.3mg/dL
|-
| colspan="3" |Potassium
|S
|3.5-5.0mmol/L
|3.5-5.0meq/L
|-
| colspan="3" |Prealbumin
|S
|170-340mg/L
|17-34mg/dL
|-
| colspan="3" |Procalcitonin
|S
|<0.1μg/L
|<0.1ng/mL
|-
| colspan="3" |Progesterone 
|S, P
|
|
|-
|
| colspan="2" |Female: 
|
|
|
|-
|
|
|Follicular 
|
|<3.18nmol/L 
|<1.0ng/mL
|-
|
|
|Midluteal 
|
|9.54-63.6nmol/L 
|3-20ng/mL 
|-
|
| colspan="2" |Male
|
|<3.18nmol/L
|<1.0ng/mL
|-
| colspan="3" |Prolactin 
|S
|
|
|-
|
| colspan="2" |Male
|
|53-360mIU/L
|2.5-17ng/mL 
|-
|
| colspan="2" |Female
|
|40-530mIU/L
|1.9-25ng/mL
|-
| colspan="3" |Prostate-specific antigen (PSA)
|S
|0.0-4.0μg/L
|0.0-4.0ng/mL
|-
| colspan="3" |Protein fractions: 
|S
|
|
|-
|
| colspan="2" |Albumin
|
|35-55g/L
|3.5 -5.5g/dL (50-60%)
|-
|
| colspan="2" |Globulin 
|
|20-35g/L
|2.0-3.5g/dL (40-50%)
|-
|
| colspan="2" |Alpha1
|
|2-4g/L
|0.2-0.4g/dL (4.2-7.2%)
|-
|
| colspan="2" |Alpha2 
|
|5-9g/L
|0.5-0. g/dL (6.8-12%)
|-
|
| colspan="2" |Beta 
|
|6-11g/L
|0.6-1.1g/dL (9.3-15%) 
|-
| colspan="3" |Gamma
|
|7-17g/L
|0.7-1.7g/dL (13-23%)
|-
|
| colspan="2" |Protein, total
|S
|67-86g/L
|6.7-8.6g/dL
|-
| colspan="3" |Pyruvate
|P
|40-130μmol/L
|0.35-1.14mg/dL
|-
| colspan="3" |Rheumatoid factor
|S
|<15kIU/L
|<15IU/mL
|-
| colspan="3" |Serotonin
|WB
|0.28-1.14umol/L
|50-200ng/mL
|-
| colspan="3" |Serum protein electrophoresis
|S
|Not applicable
|Normal pattern
|-
| colspan="3" |Sex hormone-binding globulin (adult
|S
|11-80nmol/L
|11-80nmol/L
|-
|
| colspan="2" |Male
|
|30-135nmol/L
|30-135nmol/L
|-
|
| colspan="2" |Female
|
|
|
|-
| colspan="3" |Sodium
|S
|136-146mmol/L
|136-146meq/L
|-
| colspan="3" |Testosterone, free
|S
|
|
|-
|
| colspan="2" |Female, adult
|
|10.4-65.9pmol/L
|3-19pg/mL
|-
|
| colspan="2" |Male, adult
|
|312-1041pmol/L
|90-300pg/mL
|-
| colspan="3" |Testosterone, total, 
|S
|
|
|-
|
| colspan="2" |Female
|
|0.21-2.98nmol/L 
|6-86ng/dL
|-
|
| colspan="2" |Male
|
|9.36-37.10nmol/L
|270-1070ng/dL
|-
| colspan="3" |Thyroglobulin
|S
|1.3-31.8μg/L
|1.3-31.8ng/mL
|-
| colspan="3" |Thyroid-binding globulin
|S
|13-30mg/L
|1.3-3.0mg/dL
|-
|
| colspan="2" |Thyroid-stimulating hormone
|S
|0.34-4.25 mIU/L
|0.34-4.25μIU/mL
|-
|
| colspan="2" |Thyroxine, free (fT4)
|S
|9.0-16pmol/L
|0.7-1.24ng/dL
|-
| colspan="3" |Thyroxine, total (T4)
|S
|70-151nmol/L
|5.4-11.7μg/dL
|-
| colspan="3" |Thyroxine index (free)
|S
|6.7-10.9
|6.7-10.9
|-
| colspan="3" |Transferrin
|S
|2.0-4.0g/L
|200-400mg/dL
|-
| colspan="3" |Triiodothyronine, free (fT3)
|S
|3.7-6.5pmol/L
|2.4-4.2pg/mL
|-
| colspan="3" |Triiodothyronine, total (T3)
|S
|1.2-2.1nmol/L
|77-135ng/dL
|-
| colspan="3" |Urea nitrogen
|S
|2.5-7.1mmol/L
|7-20mg/dL
|-
| colspan="3" |Uric acid
|S
|
|
|-
|
| colspan="2" |Females
|
|0.15-0.33mmol/L 
|2.5-5.6mg/dL 
|-
|
| colspan="2" |Males
|
|0.18-0.41mmol/L
|3.1-7.0mg/dL
|-
| colspan="3" |Vasoactive intestinal polypeptide
|P
|0-60ng/L
|0-60 g/mL
|}